Characterization and complete genome analysis of Bacillus velezensis CB6 revealed ATP synthase subunit α against foodborne pathogens

Analysis of Bioactive Compounds Produced by Bacillus mojavensis ZA1 and Their Antagonistic Effect on Colletotrichum coccodes by GC-MS

The plant disease Colletotrichum coccodes, which lowers potato yields, poses a severe danger to the booming potato industry. Isolated plant endophytic bacteria from highland pasture can produce a variety of metabolites that lessen the risk that the pathogen C. coccodes poses to plant growth and development. Therefore, the objective of our work was to assess substances with antipathogenic properties made by the endophytic bacteria Bacillus mojavensis ZA1. Gas chromatography-mass spectrometry (GC-MS) was used in our investigation to accomplish a thorough structural elucidation of the antipathogenic compounds produced by the endophytic bacterial strain B. mojavensis ZA1. The results showed that the metabolites extracted from ethyl acetate as an extractant were the most effective in inhibiting the pathogen C. coccodes, with 60.95% inhibition. Thirty-five distinct chemicals, including acids, esters, ketones, alcohols, amino acid ammonium salts, cyclic ethers, aromatic hydrocarbons, and heterocyclic compounds, were among the metabolites that may inhibit C. coccodes. Further analysis of the chemical groups in the compound structures revealed the potential of driving groups, such as hydroxyl, carbonyl, ester, benzene, carbon-carbon double bonds, and carbon rings, that prevent C. coccodes from performing its function. This study opens up new opportunities for plant protection programs by demonstrating that natural chemicals produced by B. mojavensis ZA1 can be used as candidates for cutting-edge plant disease management treatments.

Discovery of a novel antibacterial protein CB6-C to target methicillin-resistant Staphylococcus aureus

Given a serious threat of multidrug-resistant bacterial pathogens to global healthcare, there is an urgent need to find effective antibacterial compounds to treat drug-resistant bacterial infections. In our previous studies, Bacillus velezensis CB6 with broad-spectrum antibacterial activity was obtained from the soil of Changbaishan, China. In this study, with methicillin-resistant Staphylococcus aureus as an indicator bacterium, an antibacterial protein was purified by ammonium sulfate precipitation, Sephadex G-75 column, QAE-Sephadex A 25 column and RP-HPLC, which demonstrated a molecular weight of 31.405 kDa by SDS-PAGE. LC–MS/MS analysis indicated that the compound was an antibacterial protein CB6-C, which had 88.5% identity with chitosanase (Csn) produced by Bacillus subtilis 168. An antibacterial protein CB6-C showed an effective antimicrobial activity against gram-positive bacteria (in particular, the MIC for MRSA was 16 μg/mL), low toxicity, thermostability, stability in different organic reagents and pH values, and an additive effect with conventionally used antibiotics. Mechanistic studies showed that an antibacterial protein CB6-C exerted anti-MRSA activity through destruction of lipoteichoic acid (LTA) on the cell wall. In addition, an antibacterial protein CB6-C was efficient in preventing MRSA infections in in vivo models. In conclusion, this protein CB6-C is a newly discovered antibacterial protein and has the potential to become an effective antibacterial agent due to its high therapeutic index, safety, nontoxicity and great stability.